Information Provided By: 
Fly News Breaks for July 11, 2019
ENDP
Jul 11, 2019 | 06:58 EDT
RBC Capital analyst Randall Stanicky downgraded Endo to Sector Perform and lowered his price target to $6 from $11, saying he now expects the company's turnaround to take more time given the opioid litigation uncertainty and its "excessive leverage". The analyst also lowers his FY20 and FY21 EBITDA targets to $1.22B and $1.23B from $1.39B and $1.41B, warning that competitive sector pressures on Endo may linger further.
News For ENDP From the Last 2 Days
There are no results for your query ENDP
